Comparison of two commercially available gamma interferon blood tests for immunodiagnosis of tuberculosis

Jose Domínguez, Juan Ruiz-Manzano, Malú De Souza-Galvão, Irene Latorre, Celia Milà, Silvia Blanco, M. Ángeles Jiménez, Cristina Prat, Alicia Lacoma, Neus Altet, Vicente Ausina

Producció científica: Contribució a revistaArticleRecercaAvaluat per experts

125 Cites (Scopus)

Resum

We evaluated the T-SPOT.TB and Quantiferon-TB Gold In tube (QFN-G-IT) tests for diagnosing Mycobacterium tuberculosis infection. T-SPOT.TB was more sensitive than QFN-G-IT in diagnosing both active and latent infection. Both gamma interferon tests were unaffected by prior Mycobacterium bovis BCG vaccination. Among children who were not BCG vaccinated but had a positive tuberculin skin test, QFN-G-IT was negative in 53.3% of cases, and T-SPOT.TB was negative in 50% of cases. Copyright © 2008, American Society for Microbiology. All Rights Reserved.
Idioma originalAnglès
Pàgines (de-a)168-171
RevistaClinical and Vaccine Immunology
Volum15
Número1
DOIs
Estat de la publicacióPublicada - 1 de gen. 2008

Fingerprint

Navegar pels temes de recerca de 'Comparison of two commercially available gamma interferon blood tests for immunodiagnosis of tuberculosis'. Junts formen un fingerprint únic.

Com citar-ho